SPORANOX Itraconazole 10 mg/mL oral liquid bottle Australia - English - Department of Health (Therapeutic Goods Administration)

sporanox itraconazole 10 mg/ml oral liquid bottle

janssen-cilag pty ltd - itraconazole, quantity: 10 mg/ml - oral liquid, solution - excipient ingredients: propylene glycol; hydroxypropylbetadex; saccharin sodium; purified water; caramel; sorbitol solution (70 per cent) (non-crystallising); sodium hydroxide; hydrochloric acid; flavour - sporanox oral solution is indicated for: * the treatment of oral and/or oesophageal candidiasis in hiv-positive or other immunocompromised patients. * prophylaxis of fungal infections in neutropenic patients.

SPORANOX Itraconazole 100mg capsule blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

sporanox itraconazole 100mg capsule blister pack

janssen-cilag pty ltd - itraconazole, quantity: 100 mg - capsule, hard - excipient ingredients: macrogol 20000; titanium dioxide; gelatin; hypromellose; indigo carmine; erythrosine; maize starch; sucrose - sporanox is indicated for use in adults for the treatment of: superficial dermatomycoses not responding to topical treatment. fungal keratitis which has failed to respond to topical treatment or where the disease is either progressing rapidly or is immediately sight threatening. pityriasis versicolor not responding to any other treatment. vulvovaginal candidiasis not responding to topical treatment. oral candidiasis in immunocompromised patients. onychomycosis caused by dermatophytes. systemic mycoses: -systemic aspergillosis, histoplasmosis, sporotrichosis. -treatment and maintenance therapy in aids patients with disseminated or chronic pulmonary histoplasmosis infection. -treatment of oropharyngeal and/or oesophageal candidiasis when fist line systemic antifungal therapy is inappropriate or has proven ineffective. -treatment of non-invasive candidiasis in non-neutropenic patients when first-line systemic antifungal therapy is inappropriate or has proven ineffective. this may be due to underlying pathology,

SPORANOX itraconazole capsule United States - English - NLM (National Library of Medicine)

sporanox itraconazole capsule

bryant ranch prepack - itraconazole (unii: 304nug5gf4) (itraconazole - unii:304nug5gf4) - itraconazole 100 mg

ITRACONAZOLE Tablets 50mg "KAKEN" (イトラコナゾール錠50mg「科研」) Japan - English - すりの適正使用協議会 RAD-AR Council, Japan

itraconazole tablets 50mg "kaken" (イトラコナゾール錠50mg「科研」)

kaken pharmaceutical co., ltd. - itraconazole - white to grayish tablet, diameter: 8.5mm, thickness: 3.7mm

JAMP ITRACONAZOLE ORAL SOLUTION 10MGML Singapore - English - HSA (Health Sciences Authority)

jamp itraconazole oral solution 10mgml

goldplus universal pte ltd - itraconazole - solution - itraconazole 10 mg/ml

SPORANOX Ireland - English - HPRA (Health Products Regulatory Authority)

sporanox

janssen-cilag ltd - itraconazole - oral solution - 10mg/ml mg/ml - itraconazole

Sporal 100mg capsules Malta - English - Medicines Authority

sporal 100mg capsules

janssen-cilag international nv turnhoutsewes 30, b-2340 beerse, belgium - itraconazole - hard capsule - itraconazole 100 mg - antimycotics for systemic use

Itraconazole 100mg Capsules Malta - English - Medicines Authority

itraconazole 100mg capsules

p & d pharmaceuticals limited - itraconazole 100 mg - hard capsule